Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma

Min-Su PARK; Kwang-Woong LEE; Nam-Joon YI; Young-Rok CHOI; Hyeyoung KIM; Geun HONG; Kyung-Suk SUH; Choon-Hyuck-David KWON; Jae-Won JOH; Suk-Koo LEE.
Journal of Korean Medical Science ; : 1360-1366, 2014.
Artículo en Inglés | WPRIM | ID: wpr-23624

Documentos relacionados

  1. Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma.
  2. The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification.
  3. [The clinical value of heat shock protein 90α in predicting the prognosis of interventional therapy for hepatocellular carcinoma].
  4. Construction of pain prediction model for patients undergoing hepatic arterial chemoembolization.
  5. ASARA, a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
  6. Clinical impact of sarcopenia in early-stage intrahepatic recurrent hepatocellular carcinoma: an association with impaired host immunity.
  7. Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization.
  8. Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.
  9. Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
  10. Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients.